Agilent Technologies, Inc.: Q3 FY2026 earnings call

What management said about Q3 FY2026, from the documents filed with the SEC on 26 August 2026: press release. Guidance figures: 4 raised, 2 new. The quarter’s numbers.

Key takeaways

Revenue rose 8.1% reported: Third-quarter revenue was $1.88 billion, up 8.1% reported and 7.3% core from $1.74 billion a year earlier. Nine-month revenue was $5.51 billion. Source
Non-GAAP EPS rose 18%: Non-GAAP net income was $459 million, or $1.62 per diluted share, up 18% from $1.37 a year earlier. The figure includes a $0.06 benefit from tariff refunds. Source
Full-year revenue and EPS raised: Both the fiscal 2026 revenue range and the non-GAAP EPS range were raised in this release. Fourth-quarter ranges were also given. Source
Life Sciences group revenue rose 11%: LDG revenue was $746 million, up 11% reported and 10% core. Its operating margin was 23.5%, against 17.6% a year earlier. Source
End markets and regions improving: Management said end markets are improving, demand in key regions is higher, and customers are responding well to new product launches. The release names no specific products. Source
Non-GAAP margin 28.3% with refunds: Non-GAAP operating margin was 28.3%, up 320 basis points from 25.1%. About 110 basis points of it is a net benefit from tariff refunds. GAAP margin was 23.6%. Source

“Agilent’s exceptional third-quarter performance reflects the sustained momentum created by our strategy, our execution discipline, and the compounding impact of the Ignite Operating System,”
Padraig McDonnell, Agilent CEO

Guidance

Area	Period	Figure	Against last quarter
Revenue Source	Fiscal year 2026	$7.49 billion to $7.51 billion	Raised from $7.39 billion to $7.49 billion
Non-GAAP operating margin expansion Source	Fiscal year 2026, at midpoint of core revenue growth guidance	over 130 basis points	Raised from 85 basis points
Non-GAAP EPS Source	Fiscal year 2026	$6.18 to $6.21	Raised from $6.00 to $6.10
Revenue Source	Fourth quarter 2026	$1.98 billion to $2.0 billion	New
Non-GAAP EPS Source	Fourth quarter 2026	$1.71 to $1.74 per share	New
Intangible amortization Source	Future quarters	approximately $27 million per quarter	Raised from approximately $18 million per quarter

What changed from last quarter

Guidance raised: Fiscal 2026 revenue guidance was raised to $7.49 billion to $7.51 billion from $7.39 billion to $7.49 billion. Source
Guidance raised: Fiscal 2026 non-GAAP EPS guidance was raised to $6.18 to $6.21 from $6.00 to $6.10. Source
Guidance raised: The fiscal 2026 non-GAAP operating margin expansion estimate, at the midpoint of core revenue growth guidance, rose to over 130 basis points from 85 basis points. Source
New guidance: Fourth-quarter 2026 revenue and non-GAAP EPS guidance was given for the first time in this release, replacing the prior third-quarter guidance. Source
New: Cash flow shows $950 million paid for businesses and intangible assets in the nine months, against $4 million a year earlier. The release does not name the transactions. Source
New: The quarter's results include a $20 million tariff refund benefit in operating income. The previous release does not mention tariff refunds. Source

Results and growth drivers

Revenue rose 8.1% reported: Third-quarter revenue was $1.88 billion, up 8.1% reported and 7.3% core from $1.74 billion a year earlier. Nine-month revenue was $5.51 billion. Source
Non-GAAP EPS rose 18%: Non-GAAP net income was $459 million, or $1.62 per diluted share, up 18% from $1.37 a year earlier. The figure includes a $0.06 benefit from tariff refunds. Source
GAAP EPS rose 8%: GAAP net income was $362 million, or $1.28 per diluted share, against $336 million and $1.18 a year earlier. Source
Full-year revenue and EPS raised: Both the fiscal 2026 revenue range and the non-GAAP EPS range were raised in this release. Fourth-quarter ranges were also given. Source

Segment results

Life Sciences group revenue rose 11%: LDG revenue was $746 million, up 11% reported and 10% core. Its operating margin was 23.5%, against 17.6% a year earlier. Source
CrossLab revenue rose 6%: ACG revenue was $786 million, up 6% reported and 5% core. Its operating margin was 34.3%, against 33.3% a year earlier. Source
Applied Markets revenue rose 7%: AMG revenue was $346 million, up 7% reported and 7% core. Its operating margin was 24.9%, against 21.8% a year earlier. Source

“We are seeing improving end markets, stronger demand in key regions, and excellent customer response to our innovative product launches.”
Padraig McDonnell, Agilent CEO

Demand, products and customers

End markets and regions improving: Management said end markets are improving, demand in key regions is higher, and customers are responding well to new product launches. The release names no specific products. Source
Offering spans instruments and services: The release describes the company's offering as instruments, software, services and expertise. It gives no revenue split by product type or customer group. Source
Currency added one point: Currency added 1 percentage point to total revenue growth, a $4 million effect on the quarter, per the reconciliation of core revenue. Source

Costs, margins and tariff refunds

Non-GAAP margin 28.3% with refunds: Non-GAAP operating margin was 28.3%, up 320 basis points from 25.1%. About 110 basis points of it is a net benefit from tariff refunds. GAAP margin was 23.6%. Source
Tariff refunds added $20 million: Tariff refunds added $20 million to operating income in the quarter and $17 million to net income, equal to $0.06 per diluted share. Source
Gross margins higher in each group: Gross margin rose in each group from a year earlier: LDG 55.5% from 50.5%, ACG 57.0% from 55.1%, and AMG 57.3% from 53.6%. Source
Transformation charges rose: Transformational initiatives charges were $37 million in the quarter, against $18 million, and $95 million for nine months, against $48 million. They are excluded from non-GAAP results. Source
Non-GAAP tax rate rose to 14.50%: The non-GAAP tax rate was 14.50%, against 12.00% a year earlier. The GAAP tax provision was $82 million, against $30 million. Source

“All of this gives us confidence in our increased outlook and our ability to sustainably outperform our end markets.”
Padraig McDonnell, Agilent CEO

Cash, debt and shareholder returns

Operating cash flow higher: Net cash from operations was $1.06 billion for the nine months, against $1.01 billion a year earlier. Source
Capital spending lower: Payments for property, plant and equipment were $249 million for the nine months, down from $314 million. Source
Buybacks and dividends paid: Share repurchases of $295 million and dividends of $216 million were paid in the nine months, against $340 million and $212 million. Source
Long-term debt raised by $600 million: The company issued $600 million of long-term debt in the nine months. Long-term debt was $3.65 billion at July 31, 2026, up from $3.05 billion at October 31, 2025. Source
Cash balance slightly lower: Cash and cash equivalents were $1.76 billion at July 31, 2026, against $1.79 billion at October 31, 2025. Source

Strategy, Ignite and acquisitions

Ignite Operating System cited: Management credited the quarter to its strategy, execution discipline and the Ignite Operating System. Source
Goodwill and intangibles rose: Goodwill rose to $5.03 billion from $4.47 billion, and other intangible assets rose to $906 million from $445 million, since October 31, 2025. Source
Acquisition costs excluded from non-GAAP: Acquisition and integration costs were $7 million in the quarter, up from $3 million, and $22 million for nine months. They are excluded from non-GAAP results. Source

Coming up, as management said on 26 August 2026

Fourth-quarter results guided: Management guided fourth-quarter 2026 revenue to $1.98 billion to $2.0 billion and non-GAAP EPS to $1.71 to $1.74 per share. Source

Earlier plans management reported on

Not stated: This release raises the fiscal 2026 non-GAAP EPS range relative to the prior guide, by 15 cents at the midpoint. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.

As filed with the SEC

Open the filing on EDGAR

Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results

Delivers strong Q3 results and raises FY26 revenue growth, margin expansion, and non-GAAP EPS guidance on continued operational momentum

Third-quarter fiscal year 2026

Revenue of $1.88 billion for the third quarter ended July 31, 2026, representing growth of 8.1% reported and up 7.3% core compared with the third quarter of fiscal year 2025.
GAAP operating margin of 23.6%, expanded by 290 basis points year-over-year and 190 basis points sequentially.
Non-GAAP operating margin of 28.3% (including an approximately 110 basis point net benefit from tariff refunds), expanded by 320 basis points year-over-year and 190 basis points sequentially.
GAAP net income of $362 million; earnings per share (EPS) of $1.28, an increase of 8% from the third quarter of fiscal year 2025.
Non-GAAP net income of $459 million (including a $17 million net benefit from tariff refunds); non-GAAP EPS of $1.62 (including a $0.06 net benefit from tariff refunds), an increase of 18% from the third quarter of fiscal year 2025.

Fiscal year 2026 improved outlook and fourth-quarter guidance

Fiscal year 2026 revenue is now expected in the range of $7.49 billion to $7.51 billion, representing a range of up 7.8% to 8.1% reported and up 5.8% to 6.0% core,(1)(5) an increase of 65 basis points at the midpoint.
Non-GAAP fiscal year 2026 operating margin expansion at the midpoint of core revenue growth guidance is now expected to be over 130 basis points (including approximately 30 basis points in net benefit from tariff refunds in the third quarter).
Non-GAAP fiscal year 2026 EPS is now expected in the range of $6.18 to $6.21, an increase of 15 cents at the midpoint (including $0.06 net benefit from tariff refunds in the third quarter) versus our prior guide.
Fourth-quarter 2026 revenue is expected in the range of $1.98 billion to $2.0 billion, growth of 6.4% to 7.4% reported and up 5.2% to 6.2% core(1)(5). Non-GAAP EPS is expected in the range of $1.71 to $1.74 per share. This guidance does not include any future benefit from tariff refunds.

SANTA CLARA, California, August 26, 2026 - Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.88 billion for the third quarter ended July 31, 2026, representing growth of 8.1% reported and up 7.3% core compared with the third quarter of fiscal year 2025.

Third-quarter GAAP net income was $362 million, or $1.28 per share. This compares with $336 million, or $1.18 per share, in the third quarter of fiscal year 2025. Non-GAAP net income was $459 million (including a $17 million net benefit from tariff refunds), or $1.62 per share (including a $0.06 net benefit from tariff refunds), during the quarter, compared with $390 million, or $1.37 per share, during the year-ago quarter.

“Agilent’s exceptional third-quarter performance reflects the sustained momentum created by our strategy, our execution discipline, and the compounding impact of the Ignite Operating System,” said Agilent CEO Padraig McDonnell. “We are seeing improving end markets, stronger demand in key regions, and excellent customer response to our innovative product launches. All of this gives us confidence in our increased outlook and our ability to sustainably outperform our end markets.”

Financial Highlights

Life Sciences and Diagnostics Markets Group

The Life Sciences and Diagnostics Markets Group (LDG) reported third-quarter revenue of $746 million, growth of 11% reported and 10% core year-over-year. LDG’s operating margin for the quarter was 23.5%.

Agilent CrossLab Group

The Agilent CrossLab Group (ACG) reported third-quarter revenue of $786 million, growth of 6% reported and 5% core year-over-year. ACG’s operating margin for the quarter was 34.3%.

Applied Markets Group

The Applied Markets Group (AMG) reported third-quarter revenue of $346 million, growth of 7% reported and 7% core year-over-year. AMG’s operating margin for the quarter was 24.9%.

Conference Call

Agilent’s management will present additional details regarding the company’s third-quarter 2026 financial results on a conference call with investors today at 1:30 p.m. PT. This event will be broadcast live online in listen-only mode. To listen to the webcast, select the “Q3 2026 Agilent Technologies, Inc. Earnings Conference Call” link on the Agilent Investor Relations website. The replay of the call will remain on the company website for 90 days.

About Agilent Technologies

Agilent Technologies, Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

Forward-Looking Statements

Forward-looking statements notice

This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding Agilent’s growth prospects, business, financial results, revenue, non-GAAP earnings guidance for fiscal year and fourth-quarter 2026, and the effects of its operational transformation and customer and market-focused strategy. These forward-looking statements involve risks and uncertainties that could cause Agilent’s results to differ materially from management’s current expectations. Such risks and uncertainties include, but are not limited to, unforeseen changes in the strength of Agilent’s customers’ businesses; unforeseen changes in the demand for current and new products, technologies, and services; unforeseen changes in the currency markets; customer purchasing decisions and timing; and the risk that Agilent is not able to realize the savings expected from integration and restructuring activities. In addition, other risks that Agilent faces in running its operations include the ability to execute successfully through business cycles; the ability to meet and achieve the benefits of its operational transformation, customer and market-focused strategy and cost-reduction goals and otherwise successfully adapt its cost structures to continuing changes in business conditions; ongoing competitive, pricing and gross-margin pressures; the risk that its cost-cutting initiatives will impair its ability to develop products and remain competitive and to operate effectively; the impact of geopolitical uncertainties and global economic conditions on its operations, its markets and its ability to conduct business; the ability to improve asset performance to adapt to changes in demand; the impact relating to or arising from changes to tariffs, import/export or trade policies; the ability of its supply chain to adapt to changes in demand; the ability to successfully introduce new products at the right time, price and mix; the ability of Agilent to successfully integrate recent acquisitions; the ability of Agilent to successfully comply with certain complex regulations; and other risks detailed in Agilent’s filings with the Securities and Exchange Commission, including its quarterly report on Form 10-Q for the fiscal quarter ended April 30, 2026. Forward-looking statements are based on the beliefs and assumptions of Agilent’s management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.

(1) Core or organic constant currency revenue growth excludes the impact of currency and acquisitions and divestitures within the past 12 months. Core or organic constant currency revenue is a non-GAAP measure. Reconciliations between GAAP revenue and core or organic constant currency revenue for third quarter 2026 are set forth on page 7 of the attached tables along with additional information regarding the use of this non-GAAP measure. Core or organic constant currency revenue growth rate as projected for fourth quarter 2026 and full fiscal year 2026 excludes the impact of currency and acquisitions and divestitures within the past 12 months. Most of the excluded amounts pertain to events that have not yet occurred and are not currently possible to estimate with a reasonable degree of accuracy and could differ materially. Therefore, no reconciliation to GAAP amounts has been provided for the projection.

(2) Non-GAAP operating margin excludes the impacts of restructuring and other related costs, intangibles amortization, transformation initiatives and acquisition and integration costs. A reconciliation between non-GAAP operating margin and GAAP operating margin is set forth on page 5 of the attached tables along with additional information regarding the use of this non-GAAP measure. Non-GAAP operating margin as projected for full fiscal year 2026 excludes primarily the impacts of restructuring and other related costs, intangible amortization, transformation initiatives and acquisition and integration costs. Most of these excluded amounts pertain to events that have not yet occurred and are not currently possible to estimate with a reasonable degree of accuracy and could differ materially. Therefore, no reconciliation to GAAP amounts has been provided.

(3) Non-GAAP net income and non-GAAP EPS exclude the impacts of restructuring and other related costs, intangibles amortization, transformational initiatives, acquisition and integration costs and net (gain) loss on equity securities. Agilent also excludes any tax benefits or expenses that are not directly related to ongoing operations, and which are either isolated or are not expected to occur again with any regularity or predictability. A reconciliation between non-GAAP net income and GAAP net income and a reconciliation between non-GAAP EPS and GAAP EPS is set forth on page 4 of the attached tables along with additional information regarding the use of this non-GAAP measure.

(4) Non-GAAP EPS as projected for fourth quarter 2026 and full fiscal year 2026 exclude primarily the estimated impacts of non-cash intangibles amortization, transformational initiatives, and acquisition and integration costs. Agilent also excludes any tax benefits or expenses that are not directly related to ongoing operations, and which are either isolated or are not expected to occur again with any regularity or predictability. Most of these excluded amounts pertain to events that have not yet occurred and are not currently possible to estimate with a reasonable degree of accuracy and could differ materially. Therefore, no reconciliation to GAAP amounts has been provided. Future amortization of intangibles is expected to be approximately $27 million per quarter.

(5) Core or organic constant currency revenue growth outlook is based on forecasted currency exchange rates.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In millions, except per share data)

(Unaudited)

PRELIMINARY

	Three Months Ended			Nine Months Ended
	July 31,			July 31,
	2026		2025	2026		2025
Net revenue	$1,878		$1,738	$5,511		$5,087
Costs and expenses:
Cost of products and services	836		850	2,533		2,434
Research and development	123		111	366		336
Selling, general and administrative	475		417	1,416		1,281
Total costs and expenses	1,434		1,378	4,315		4,051
Income from operations	444		360	1,196		1,036
Interest income	15		16	43		45
Interest expense	(29)		(28)	(79)		(85)
Other income (expense), net	14		18	56		(3)
Income before taxes	444		366	1,216		993
Provision for income taxes	82		30	210		124
Net income	$362		$336	$1,006		$869
Net income per share:
Basic	$1.28		$1.18	$3.55		$3.05
Diluted	$1.28		$1.18	$3.55		$3.05
Weighted average shares used in computing net income per share:
Basic		282	284		283	285
Diluted		283	285		283	285

The preliminary income statement is estimated based on our current information.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In millions, except par value and share data)

(Unaudited)

PRELIMINARY

		July 31, 2026	October 31, 2025
ASSETS
Current assets:
Cash and cash equivalents		$1,758	$1,789
Accounts receivable, net		1,478	1,487
Inventory		1,117	1,025
Other current assets		340	293
Total current assets		4,693	4,594
Property, plant and equipment, net		2,134	2,023
Goodwill		5,030	4,473
Other intangible assets, net		906	445
Long-term investments		130	133
Other assets		1,074	1,059
Total assets		$13,967	$12,727
LIABILITIES AND EQUITY
Current liabilities:
Accounts payable		$608	$570
Employee compensation and benefits		423	443
Deferred revenue		640	624
Short-term debt		304	304
Other accrued liabilities		314	406
Total current liabilities		2,289	2,347
Long-term debt		3,645	3,050
Retirement and post-retirement benefits		128	126
Other long-term liabilities		542	463
Total liabilities		6,604	5,986
Total Equity:
Stockholders' equity:
Preferred stock; $0.01 par value; 125,000,000 shares authorized; none issued and outstanding	3	-	-
Common stock; $0.01 par value; 2,000,000,000 shares authorized; 281,965,813 shares at July 31, 2026 and 283,054,377 shares at October 31, 2025, issued and outstanding		3	3
Additional paid-in-capital		5,681	5,575
Retained earnings		1,912	1,389
Accumulated other comprehensive loss		(233)	(226)
Total stockholders' equity		7,363	6,741
Total liabilities and stockholders' equity		$13,967	$12,727

The preliminary balance sheet is estimated based on our current information.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions)

(Unaudited)

PRELIMINARY

	Nine Months Ended
	July 31,	July 31,
	2026	2025
Cash flows from operating activities:
Net income	$1,006	$869
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	200	217
Share-based compensation	105	102
Deferred taxes expense (benefit)	77	(35)
Excess and obsolete inventory related charges	35	30
Net (gain) loss on equity securities	2	28
Asset impairment charges	-	15
Other non-cash (income) expense, net	12	4
Changes in assets and liabilities:
Accounts receivable, net	16	(44)
Inventory	(110)	(72)
Accounts payable	41	(13)
Employee compensation and benefits	(25)	(26)
Other assets and liabilities	(295)	(61)
Net cash provided by operating activities	1,064	1,014
Cash flows from investing activities:
Payments to acquire property, plant and equipment	(249)	(314)
Proceeds from sale of equity securities	-	5
Proceeds from convertible note	-	2
Payments in exchange for convertible note	(3)	(1)
Payments to acquire businesses and intangible assets, net of cash acquired	(950)	4
Net cash used in investing activities	(1,202)	(304)
Cash flows from financing activities:
Proceeds from issuance of common stock under employee stock plans	63	60
Payment of taxes related to net share settlement of equity awards	(31)	(28)
Payments for repurchase of common stock	(295)	(340)
Payment of excise taxes related to repurchases of common stock	(3)	(10)
Payments of dividends	(216)	(212)
Proceeds from issuance of long-term debt	600	4
Repayments of long-term debt	(4)	(2)
Payments of debt issuance costs	(5)	-
Net proceeds from (repayment of) short-term debt	-	13
Payments of finance lease	(4)	-
Net cash provided by (used in) financing activities	105	(515)
Effect of exchange rate movements	2	10
Net increase (decrease) in cash, cash equivalents and restricted cash	(31)	205
Cash, cash equivalents and restricted cash at beginning of period	1,791	1,332
Cash, cash equivalents and restricted cash at end of period	$1,760	$1,537
Reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets:
Cash and cash equivalents	$1,758	$1,535
Restricted cash, included in other assets	2	2
Total cash, cash equivalents and restricted cash	$1,760	$1,537
Cash payments included in operating activities:
Income tax payments, net of refunds received	$376	$304
Interest payments, net of capitalized interest	$47	$55
Net change in property, plant and equipment included in accounts payable and accrued liabilities-increase (decrease)	$(9)	$ -
Excise tax on share repurchases, accrued but not paid	$2	$2

The preliminary cash flow is estimated based on our current information.

NON-GAAP NET INCOME AND DILUTED EPS RECONCILIATIONS

(In millions, except per share data)

(Unaudited)

PRELIMINARY

	Three Months Ended				Nine Months Ended
	July 31,				July 31,
	2026		2025		2026		2025
	Net Income	Diluted EPS	Net Income	Diluted EPS	Net Income	Diluted EPS	Net Income	Diluted EPS
GAAP net income	$362	$1.28	$336	$1.18	$1,006	$3.55	$869	$3.05
Non-GAAP adjustments:
Restructuring and other related costs	15	0.05	17	0.06	43	0.15	74	0.26
Asset impairments	-	-	-	-	-	-	15	0.05
Intangible amortization	21	0.07	26	0.09	59	0.21	81	0.28
Transformational initiatives	37	0.13	18	0.06	95	0.34	48	0.17
Acquisition and integration costs	7	0.02	3	0.01	22	0.08	15	0.05
Net (gain) loss on equity securities	5	0.02	1	-	6	0.02	28	0.10
Pension settlement loss	-	-	-	-	-	-	14	0.05
Other	8	0.03	12	0.05	42	0.15	27	0.09
Adjustment for taxes	4	0.02	(23)	(0.08)	(5)	(0.02)	(31)	(0.10)
Non-GAAP net income	$459	$1.62	$390	$1.37	$1,268	$4.48	$1,140	$4.00

The adjustment for taxes excludes tax expense (benefits) that management believes are not directly related to on-going operations and which are either isolated, temporary or cannot be expected to occur again with any regularity or predictability such as the realized gain/loss due to sale of a business, windfall benefits on stock compensation, and the impact of R&D capitalization under section 174 of the Tax Cuts and Jobs Act of 2017 which does not apply for fiscal year 2026 due to the enactment of the One Big Beautiful Bill Act (OBBBA). For the three and nine months ended July 31, 2026, management used a non-GAAP effective tax rate of 14.50%. For the three and nine months ended July 31, 2025, management used a non-GAAP effective tax rate of 12.00%.

(b) GAAP and Non-GAAP net income of $362 million and $459 million, respectively, includes a $17 million net benefit from tariff refunds. GAAP and Non-GAAP EPS of $1.28 and $1.62, respectively, includes a $0.06 net benefit from tariff refunds.

(c) GAAP and Non-GAAP net income of $1,006 million and $1,268 million, respectively, includes a $17 million net benefit from tariff refunds. GAAP and Non-GAAP EPS of $3.55 and $4.48, respectively, includes a $0.06 net benefit from tariff refunds.

We provide non-GAAP net income and non-GAAP net income per share amounts in order to provide meaningful supplemental information regarding our operational performance and our prospects for the future. These supplemental measures exclude, among other things, charges related to restructuring and other related costs, asset impairments, amortization of intangibles, transformational initiatives, acquisition and integration costs, net (gain) loss on equity securities and pension settlement loss.

Restructuring and other related costs include incremental expenses incurred in the period associated with restructuring programs, usually aimed at changes in business and/or cost structure. Such costs may include one-time termination benefits including acceleration of stock-based compensation expense, facility-related costs and contract termination fees.

Asset impairments include assets that have been written down to their fair value.

Intangible amortization refers to the systematic expensing of the cost of finite‑lived intangible assets over their estimated useful lives. Such assets, which include acquired patents, trademarks, customer lists, and other identifiable intangibles, are amortized to match the pattern in which their economic benefits are consumed. If the useful life is not reliably determinable, amortization is calculated on a straight‑line basis over the best estimate of that life.

Transformational initiatives include expenses associated with targeted cost reduction activities such as manufacturing transfers including costs to move manufacturing, site consolidations, legal entity and other business reorganizations, insourcing or outsourcing of activities. Such costs may include move and relocation costs, one-time termination benefits and other one-time reorganization costs. Included in this category are also expenses associated with company programs to transform our product lifecycle management (PLM) system and human resources and financial systems.

Acquisition and integration costs include all incremental expenses incurred to effect a business combination. Such acquisition costs may include advisory, legal, tax, accounting, valuation, and other professional or consulting fees. Such integration costs may include expenses directly related to integration of business and facility operations, the transfer of assets and intellectual property, information technology systems and infrastructure and other employee-related costs.

Net (gain) loss on equity securities relates to the realized and unrealized mark-to-market adjustments for our marketable and non-marketable equity securities.

Pension settlement loss resulted from the transfer of the Netherlands defined benefit plan to an unaffiliated insurance company.

Other includes certain legal costs and settlements, consulting costs, special compliance costs, acceleration of stock-based compensation expense and other miscellaneous adjustments.

Our management uses non-GAAP measures to evaluate the performance of our core businesses, to estimate future core performance and to compensate employees. Since management finds this measure to be useful, we believe that our investors benefit from seeing our results “through the eyes” of management in addition to seeing our GAAP results. This information facilitates our management’s internal comparisons to our historical operating results as well as to the operating results of our competitors.

Our management recognizes that items such as amortization of intangibles can have a material impact on our cash flows and/or our net income. Our GAAP financial statements including our statement of cash flows portray those effects. Although we believe it is useful for investors to see core performance free of special items, investors should understand that the excluded items are actual expenses that may impact the cash available to us for other uses. To gain a complete picture of all effects on the company’s profit and loss from any and all events, management does (and investors should) rely upon the GAAP income statement. The non-GAAP numbers focus instead upon the core business of the company, which is only a subset, albeit a critical one, of the company’s performance.

Readers are reminded that non-GAAP numbers are merely a supplement to, and not a replacement for, GAAP financial measures. They should be read in conjunction with the GAAP financial measures. It should be noted as well that our non-GAAP information may be different from the non-GAAP information provided by other companies.

The preliminary non-GAAP net income and diluted EPS reconciliation is estimated based on our current information.

							Year Over Year
			Operating			Operating	Percent Pts
	Q3'26		Margin %	Q3'25		Margin %	Inc/(Dec)
AGILENT TECHNOLOGIES, INC.
RECONCILIATION OF NON-GAAP INCOME FROM OPERATIONS AND OPERATING MARGIN
(In millions, except margin data)
(Unaudited)
PRELIMINARY
GAAP revenue:	$1,878			$1,738
Income from operations:
GAAP Income from operations	$444		23.6%	$360		20.7%
Non-GAAP adjustments:
Restructuring and other related costs		15			17
Intangible amortization		21			26
Transformational initiatives		37			18
Acquisition and integration costs		7			3
Other		8			13
Non-GAAP income from operations	$532		28.3%	$437		25.1%	3.2%
(a) GAAP and non-GAAP income from operations of $444 million and $532 million, respectively, includes a $20 million net benefit from tariff refunds. GAAP and non-GAAP operating margin of 23.6% and 28.3%, respectively, includes a 110 basis points net benefit from tariff refunds.
We provide non-GAAP income from operations and non-GAAP operating margin amounts in order to provide meaningful supplemental information regarding our operational performance and our prospects for the future. These supplemental measures exclude, among other things, charges related to restructuring and other related costs, amortization of intangibles, transformational initiatives and acquisition and integration costs.
Our management recognizes that items such as amortization of intangibles can have a material impact on our cash flows and/or our net income. Our GAAP financial statements including our statement of cash flows portray those effects. Although we believe it is useful for investors to see core performance free of special items, investors should understand that the excluded items are actual expenses that may impact the cash available to us for other uses. To gain a complete picture of all effects on the company’s profit and loss from any and all events, management does (and investors should) rely upon the GAAP income statement. The non-GAAP numbers focus instead upon the core business of the company, which is only a subset, albeit a critical one, of the company’s performance.
Readers are reminded that non-GAAP numbers are merely a supplement to, and not a replacement for, GAAP financial measures. They should be read in conjunction with the GAAP financial measures. It should be noted as well that our non-GAAP information may be different from the non-GAAP information provided by other companies.
The preliminary reconciliation of income from operations and operating margins is estimated based on our current information.

SEGMENT INFORMATION

(In millions, except where noted)

(Unaudited)

PRELIMINARY

Quarter-over-Quarter

Life Sciences and Diagnostics Markets Segment

	Q3'26	Q3'25
Revenue	$746	$670
Gross Margin, %	55.5%	50.5%
Income from Operations	$176	$118
Operating margin, %	23.5%	17.6%

Agilent CrossLab Segment

	Q3'26	Q3'25
Revenue	$786	$744
Gross Margin, %	57.0%	55.1%
Income from Operations	$270	$248
Operating margin, %	34.3%	33.3%

Applied Markets Segment

	Q3'26	Q3'25
Revenue	$346	$324
Gross Margin, %	57.3%	53.6%
Income from Operations	$86	$71
Operating margin, %	24.9%	21.8%

Income from operations reflect the results of our reportable segments under Agilent's management reporting system which are not necessarily in conformity with GAAP financial measures. Income from operations of our reporting segments exclude, among other things, charges related to restructuring and other related costs, amortization of intangibles, transformational initiatives, acquisition and integration costs and net (gain) loss on equity securities.

The preliminary segment information is estimated based on our current information.

RECONCILIATIONS OF REVENUE BY SEGMENT

EXCLUDING ACQUISITIONS, DIVESTITURES AND THE IMPACT OF CURRENCY ADJUSTMENTS (CORE)

(In millions)

(Unaudited)

PRELIMINARY

	Year-over-Year
	GAAP
GAAP Revenue by Segment	Q3'26	Q3'25	Year-over-Year % Change
Life Sciences and Diagnostics Markets Segment	$746	$670	11%
Agilent CrossLab Segment	786	744	6%
Applied Markets Segment	346	324	7%
Agilent	$1,878	$1,738	8%
	Non-GAAP (excluding Acquisitions & Divestitures)			Year-over-Year at Constant Currency
Non-GAAP Revenue by Segment	Q3'26	Q3'25	Year-over-Year % Change	Year-over-Year % Change	Percentage Point Impact from Currency	Current Quarter Currency Impact
Life Sciences and Diagnostics Markets Segment	$736	$670	10%	10%	-	$1
Agilent CrossLab Segment	786	744	6%	5%	1 ppt	2
Applied Markets Segment	346	324	7%	7%	-	1
Agilent (Core)	$1,868	$1,738	8%	7%	1 ppt	$4

We compare the year-over-year change in revenue excluding the effect of recent acquisitions and divestitures and foreign currency rate fluctuations to assess the performance of our underlying business.

The constant currency year-over-year growth percentage is calculated by recalculating all periods in the comparison period at the foreign currency exchange rates used for accounting during the last month of the current quarter and then using those revised values to calculate the year-over-year percentage change.

The dollar impact from the current quarter currency impact is equal to the total year-over-year dollar change less the constant currency year-over-year change.

The preliminary reconciliation of GAAP revenue adjusted for recent acquisitions and divestitures and impact of currency is estimated based on our current information.

Contacts
Tejas Savant
+1 917-574-4018 tejas.savant@agilent.com
Andréa Topper
408-709-0060 andrea.topper@agilent.com